Prognostic significance of adiponectin levels in non-metastatic colorectal cancer

Patrizia Ferroni, Raffaele Palmirotta, Antonella Spila, Francesca Martini, Valeria Raparelli, Emanuela Fossile, Sabrina Mariotti, Girolamo Del Monte, Oreste Buonomo, Mario Roselli, Fiorella Guadagni

Research output: Contribution to journalArticlepeer-review


Background: Circulating adiponectin levels are inversely correlated with the risk of colorectal cancer (CRC). This study was designed to evaluate the association between adiponectin levels and the clinicopathological variables of CRC and to analyze the possible prognostic value of adiponectin in predicting relapse-free survival. Patients and Methods: Baseline adiponectin and serum tumor markers were analyzed in 60 patients with non-metastatic CRC followed-up from time of surgery for at least three years or until relapse. Results: The median adiponectin levels were lower in CRC patients (8.3 μg/ml) than controls (13.1 μg/ml, p

Original languageEnglish
Pages (from-to)483-489
Number of pages7
JournalAnticancer Research
Issue number1 B
Publication statusPublished - Jan 2007


  • Adiponectin
  • Colorectal cancer
  • Prognosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Prognostic significance of adiponectin levels in non-metastatic colorectal cancer'. Together they form a unique fingerprint.

Cite this